Article Text

Download PDFPDF

Establishing a tele-clinic service for kidney transplant recipients through a patient-codesigned quality improvement project
  1. Udaya Prabhakar Udayaraj1,2,
  2. Oliver Watson2,
  3. Yoav Ben-Shlomo3,
  4. Maria Langdon4,
  5. Karen Anderson4,
  6. Albert Power4,
  7. Christopher Dudley4,
  8. David Evans5,
  9. Anna Burhouse6
  1. 1Oxford Kidney Unit, Churchill Hospital, Oxford, UK
  2. 2Bristol Health Partners, Bristol, UK
  3. 3Population Health sciences, University of Bristol Medical School, Bristol, UK
  4. 4Richard Bright Renal Unit, North Bristol NHS Trust, Bristol, UK
  5. 5West of England Academic Health Science Network, Bristol, UK
  6. 6Rubis.Qi, Northumbria Healthcare NHS Foundation Trust, North Shields, UK
  1. Correspondence to Dr Udaya Prabhakar Udayaraj; udaya.udayaraj{at}ouh.nhs.uk

Footnotes

  • Contributors UPU developed the idea of tele-clinic, led the project and wrote the manuscript. OW was the project manager collecting and analysing data. YB-S contributed to the project set up and commented on the manuscript. ML, KA, AP and CD conducted the tele-clinics and contributed to data collection. DE and AB provided expertise on quality improvement methodology and commented on the manuscript.

  • Funding We would like to thank the West of England Academic Health Sciences Network for their quality improvement expertise and for funding this project.

  • Competing interests AP reports personal fees from Vifor Fresenius Renal Pharma, personal fees from Bayer GmBH outside the submitted work.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors UPU developed the idea of tele-clinic, led the project and wrote the manuscript. OW was the project manager collecting and analysing data. YB-S contributed to the project set up and commented on the manuscript. ML, KA, AP and CD conducted the tele-clinics and contributed to data collection. DE and AB provided expertise on quality improvement methodology and commented on the manuscript.

  • Funding We would like to thank the West of England Academic Health Sciences Network for their quality improvement expertise and for funding this project.

  • Competing interests AP reports personal fees from Vifor Fresenius Renal Pharma, personal fees from Bayer GmBH outside the submitted work.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.